221 related articles for article (PubMed ID: 6337218)
21. In situ identification of T lymphocyte subsets and HLA-DR expressing cells in the human skin tuberculin reaction.
Scheynius A; Klareskog L; Forsum U
Clin Exp Immunol; 1982 Aug; 49(2):325-30. PubMed ID: 6751638
[TBL] [Abstract][Full Text] [Related]
22. Loss of epidermal Langerhans' cells and endothelial cell HLA-DR antigens in the skin in progressive systemic sclerosis.
Andrews BS; Friou GJ; Barr RJ; Mirick GR; Berman M; Sandborg C; Ross PA
J Rheumatol; 1986 Apr; 13(2):341-8. PubMed ID: 2941574
[TBL] [Abstract][Full Text] [Related]
23. OKT6 is not superior to HLA-DR or ATPase as a marker for Langerhans' cells in normal human epidermis.
Liu HH; Schroeter AL; Muller SA
Clin Exp Dermatol; 1986 May; 11(3):229-37. PubMed ID: 2943537
[No Abstract] [Full Text] [Related]
24. Expression of CD1 and HLA-DR by Langerhans cells (LC) in oral lichenoid drug eruptions (LDE) and idiopathic oral lichen planus (LP).
McCartan BE; Lamey PJ
J Oral Pathol Med; 1997 Apr; 26(4):176-80. PubMed ID: 9176792
[TBL] [Abstract][Full Text] [Related]
25. Effect of UVA and UVB irradiation on human epidermal Langerhans cell membrane markers defined by ATPase activity and monoclonal antibodies (OKT 6 and anti-Ia).
Koulu L; Jansén CT; Viander M
Photodermatol; 1985 Dec; 2(6):339-46. PubMed ID: 2937025
[TBL] [Abstract][Full Text] [Related]
26. The relationship between T lymphocyte subsets and Ia-like antigen positive nonlymphoid cells in early stages of cutaneous T cell lymphoma.
Thomas JA; Janossy G; Graham-Brown RA; Kung PC; Goldstein G
J Invest Dermatol; 1982 Feb; 78(2):169-76. PubMed ID: 7035573
[TBL] [Abstract][Full Text] [Related]
27. Role of HLA-DR bearing Langerhans and epidermal indeterminate cells in the in vitro generation of alloreactive cytotoxic T cells in man.
Faure M; Frappaz A; Schmitt D; Dezutter-Dambuyant C; Thivolet J
Cell Immunol; 1984 Feb; 83(2):271-9. PubMed ID: 6229342
[TBL] [Abstract][Full Text] [Related]
28. Oral mucosal Langerhans cells express DR and DQ antigens.
Walsh LJ; Seymour GJ; Savage NW
J Dent Res; 1986 Mar; 65(3):390-3. PubMed ID: 3457041
[TBL] [Abstract][Full Text] [Related]
29. Use of the fluorescence-activated cell sorter to quantitate and enrich for subpopulations of human skin cells.
Morhenn VB; Benike CJ; Charron DJ; Cox A; Mahrle G; Wood GS; Engleman EG
J Invest Dermatol; 1982 Nov; 79(5):277-82. PubMed ID: 6752290
[TBL] [Abstract][Full Text] [Related]
30. Dual expression of the cell-surface antigens HLA-DR and CD1 (T6) by Langerhans cells in human buccal mucosa and skin.
Cruchley AT; Speight PM; Williams DM
Arch Oral Biol; 1987; 32(11):849-53. PubMed ID: 2452627
[TBL] [Abstract][Full Text] [Related]
31. Flow cytometrically-sorted residual HLA-DR+T6+ Langerhans cells in topical steroid-treated human skin express normal amounts of HLA-DR and CD1a/T6 antigens and exhibit normal alloantigen-presenting capacity.
Ashworth J; Kahan MC; Breathnach SM
J Invest Dermatol; 1989 Feb; 92(2):258-62. PubMed ID: 2783952
[TBL] [Abstract][Full Text] [Related]
32. Langerhans' cell and vitiligo: quantitative study of T6 and HLA-DR antigen-expressing cells.
Claudy AL; Rouchouse B
Acta Derm Venereol; 1984; 64(4):334-6. PubMed ID: 6209893
[TBL] [Abstract][Full Text] [Related]
33. Recombinant gamma interferon induces HLA-DR expression on cultured human keratinocytes.
Basham TY; Nickoloff BJ; Merigan TC; Morhenn VB
J Invest Dermatol; 1984 Aug; 83(2):88-90. PubMed ID: 6206165
[TBL] [Abstract][Full Text] [Related]
34. Immunological markers of Langerhans' cells in mycosis fungoides skin lesions.
Tjernlund U
Acta Derm Venereol; 1982; 62(3):241-3. PubMed ID: 6179366
[TBL] [Abstract][Full Text] [Related]
35. An immunohistochemical and immunoelectron microscopic study of the ontogeny of rat Langerhans cell lineage with anti-macrophage and anti-Ia monoclonal antibodies.
Hsiao L; Takeya M; Arao T; Takahashi K
J Invest Dermatol; 1989 Dec; 93(6):780-6. PubMed ID: 2584744
[TBL] [Abstract][Full Text] [Related]
36. Staining of Langerhans cells with monoclonal antibodies to macrophages and lymphoid cells.
Haines KA; Flotte TJ; Springer TA; Gigli I; Thorbecke GJ
Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3448-51. PubMed ID: 6574493
[TBL] [Abstract][Full Text] [Related]
37. Distribution of cell surface antigens in histiocytosis X cells. Quantitative immunoelectron microscopy using monoclonal antibodies.
Murphy GF; Harrist TJ; Bhan AK; Mihm MC
Lab Invest; 1983 Jan; 48(1):90-7. PubMed ID: 6337297
[TBL] [Abstract][Full Text] [Related]
38. In vitro studies of epidermal antigen-presenting cells. The mixed skin lymphocyte reaction: an in vitro model for the generation of alloreactive cytotoxic T cells by human epidermal cells.
Faure M; Schmitt D; Dezutter-Dambuyant C; Frappaz A; Gaucherand M; Thivolet J
Br J Dermatol; 1984 Jul; 111 Suppl 27():11-7. PubMed ID: 6234919
[TBL] [Abstract][Full Text] [Related]
39. Ia+ murine epidermal Langerhans cells are deficient in surface expression of the class I major histocompatibility complex.
Caughman SW; Sharrow SO; Shimada S; Stephany D; Mizuochi T; Rosenberg AS; Katz SI; Singer A
Proc Natl Acad Sci U S A; 1986 Oct; 83(19):7438-42. PubMed ID: 3532113
[TBL] [Abstract][Full Text] [Related]
40. Behavior of cutaneous Langerhans' cells and skin reactivity after gold sodium thiomalate treatment of pemphigus vulgaris.
Blitstein-Willinger E
Dermatologica; 1987; 174(2):68-75. PubMed ID: 3104105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
